BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARャ pathway
Hyung-Sik Kim1,2,3,* (Professor), Ji-Su Ahn1,2,# (Graduate student), Ji Won Yang1,2,# (Graduate student), Su-Jeong Oh1,2 (Graduate student), Ye Young Shin1,2 (Graduate student), Min-Jung Kang3 (Research worker), Hae Ryoun Park3,4 (Professor), Yoojin Seo3 (Research worker)
1Department of Life Science in Dentistry, School of Dentistry, Pusan National University,
2Dental and Life Science Institute, Pusan National University,
3Periodontal Disease Signaling Network Research Center, Dental & Life Science Institute, Pusan National University,
4Department of Oral Pathology, School of Dentistry, Pusan National University
Periodontal diseases have been reported to have a multidirectional association with metabolic disorders. We sought to investigate the correlation between periodontitis and diabetes or fatty liver disease using HFD-fed obese mice inoculated with P. gingivalis. Body weight, alveolar bone loss, serological biochemistry, and glucose level were determined to evaluate the pathophysiology of periodontitis and diabetes. For the evaluation of fatty liver disease, hepatic nonalcoholic steatohepatitis (NASH) was assessed by scoring steatosis, inflammation, hepatocyte ballooning and the crucial signaling pathways involved in liver metabolism were analyzed. The C-reactive protein (CRP) level and NASH score in P. gingivalis-infected obese mice were significantly elevated. Particularly, the extensive lobular inflammation was observed in the liver of obese mice infected with P. gingivalis. Moreover, the expression of metabolic regulatory factors, including peroxisome proliferator-activated receptor ャ (Pparャ) and the fatty acid transporter Cd36, was up-regulated in the liver of P. gingivalis-infected obese mice. However, inoculation of P. gingivalis had no significant influence on glucose homeostasis, insulin resistance, and hepatic mTOR/AMPK signaling. In conclusion, our results indicate that P. gingivalis can induce the progression of fatty liver disease in HFD-fed mice through the upregulation of CD36-PPARャ axis.
Abstract, Accepted Manuscript(in press) [Submitted on April 8, 2021, Accepted on April 28, 2021]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd